SFP
JAZZ icon

Santa Fe Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Santa Fe Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-19,418
Closed -$2.73M – 158
2015
Q4 		$2.73M Buy
19,418
+16,550
+577% +$2.29M 0.45% 76
2015
Q3 		$381K Buy
+2,868
New +$494K 0.05% 380
2015
Q2 		– Sell
-8,964
Closed -$1.55M – 535
2015
Q1 		$1.55M Buy
+8,964
New +$1.54M 0.19% 232
2014
Q4 		– Sell
-20,070
Closed -$3.22M – 548
2014
Q3 		$3.22M Buy
+20,070
New +$3.09M 0.5% 29
2013
Q3 		– Sell
-23,552
Closed -$1.62M – 531
2013
Q2 		$1.62M Buy
+23,552
New +$1.44M 0.33% 117

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Santa Fe Partners's JAZZ Position: Q1 2016 in Review

Santa Fe Partners sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2016, closing a stake of 19,418 shares — an estimated $2.73M sold.

Santa Fe Partners first reported a position in JAZZ in Q2 2013 and held it in 5 quarters. The position peaked at $3.22M in Q3 2014. 339 funds tracked by Wall St. Rank hold JAZZ as of Q1 2016.

  • Santa Fe Partners reported no remaining Jazz Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Santa Fe Partners sold 19,418 Jazz Pharmaceuticals shares in Q1 2016, an estimated $2.73M.
  • Santa Fe Partners first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • Santa Fe Partners's Jazz Pharmaceuticals position peaked at $3.22M in Q3 2014.
  • 339 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2016.

Based on Santa Fe Partners's 13F filing for Q1 2016.